From work to workout

Life Time reveals details of first Houston coworking space

Houston snags only the third location of Life Time Work. It opens in City Centre early next year. Courtesy of Life Time

Houston is just the third city to be chosen to have a location of Minnesota-based Life Time's new coworking center. Life Time Work should be open in early 2019 in City Centre Five, adjacent to Life Time Athletic.

The first Life Time Work opened in Pennsylvania, and the second will open just outside of Minneapolis ahead of Houston's location in early 2019. Other locations are expected to be announced in the next five years, according to a release.

"We all have seen the impact of technology advancements and other changes influencing how work gets done. However, workspaces haven't adapted nearly enough to address this evolution," says Bahram Akradi, founder, chairman, and CEO of Life Time.

The 25,000-square-foot City Centre space will have both private and open-plan office space with 48 rentable offices and conference rooms, phone rooms, and open meeting space.

Life Time Work has three types of memberships — private office, reserved desk, or access to the lounge. Members have access to events, food, and coffee. The coworking space also boasts month to month membership, Herman Miller furniture, unlimited wifi, and printing, copying, scanning, and shredding services.

Month-to-month memberships

Courtesy of Life Time

"We have carefully considered every detail to uniquely address the needs of accomplished professionals seeking an alternative to the traditional long-term lease or challenges faced by remote teams working from their homes," says Akradi.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News